Intrinsiqs

Is MBX Biosciences, Inc. Common Stock overvalued?

MBX Biosciences, Inc. Common Stock (MBX) — key valuation metrics and fundamentals.

No verdict
Price
$57.52
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$2.74B
Dividend yield
0.0%
Return on equity
-26.0%
Sector
Healthcare

See the full interactive analysis →

Fair value compares MBX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.